Merit Medical Systems (NASDAQ:MMSI) Posts Quarterly Earnings Results, Beats Expectations By $0.08 EPS

Merit Medical Systems (NASDAQ:MMSI) released its quarterly earnings results on Tuesday. The medical instruments supplier reported $1.04 earnings per share for the quarter, beating analysts’ consensus estimates of $0.96 by $0.08, FiscalAI reports. The company had revenue of $393.94 million for the quarter, compared to analyst estimates of $390.77 million. Merit Medical Systems had a net margin of 8.02% and a return on equity of 14.27%. Merit Medical Systems updated its FY 2026 guidance to 4.010-4.150 EPS.

Merit Medical Systems Stock Performance

Merit Medical Systems stock traded up $0.82 during mid-day trading on Tuesday, reaching $82.43. The company’s stock had a trading volume of 1,038,414 shares, compared to its average volume of 724,878. The firm’s fifty day moving average price is $84.17 and its two-hundred day moving average price is $85.01. The company has a debt-to-equity ratio of 0.48, a quick ratio of 2.86 and a current ratio of 4.28. Merit Medical Systems has a 12-month low of $77.62 and a 12-month high of $107.27. The company has a market capitalization of $4.89 billion, a P/E ratio of 42.27, a PEG ratio of 2.23 and a beta of 0.61.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on MMSI shares. Needham & Company LLC restated a “buy” rating and issued a $108.00 target price on shares of Merit Medical Systems in a research note on Friday, January 9th. Wells Fargo & Company cut their price objective on Merit Medical Systems from $103.00 to $95.00 and set an “overweight” rating on the stock in a research report on Friday, November 14th. Weiss Ratings restated a “hold (c)” rating on shares of Merit Medical Systems in a research note on Monday, December 29th. Barrington Research reaffirmed an “outperform” rating and set a $106.00 target price on shares of Merit Medical Systems in a research report on Friday, November 14th. Finally, Robert W. Baird set a $108.00 price target on shares of Merit Medical Systems in a report on Tuesday, December 16th. Nine analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $105.67.

Hedge Funds Weigh In On Merit Medical Systems

Hedge funds have recently made changes to their positions in the stock. Lido Advisors LLC lifted its holdings in Merit Medical Systems by 3.8% during the 4th quarter. Lido Advisors LLC now owns 3,836 shares of the medical instruments supplier’s stock worth $324,000 after purchasing an additional 140 shares in the last quarter. Maryland State Retirement & Pension System lifted its holdings in shares of Merit Medical Systems by 2.1% in the fourth quarter. Maryland State Retirement & Pension System now owns 8,693 shares of the medical instruments supplier’s stock worth $766,000 after buying an additional 180 shares in the last quarter. CANADA LIFE ASSURANCE Co boosted its position in shares of Merit Medical Systems by 0.4% in the third quarter. CANADA LIFE ASSURANCE Co now owns 50,667 shares of the medical instruments supplier’s stock valued at $4,095,000 after acquiring an additional 189 shares during the period. Cerity Partners LLC boosted its position in shares of Merit Medical Systems by 9.1% in the second quarter. Cerity Partners LLC now owns 3,019 shares of the medical instruments supplier’s stock valued at $282,000 after acquiring an additional 251 shares during the period. Finally, Wedbush Securities Inc. grew its stake in Merit Medical Systems by 7.3% during the fourth quarter. Wedbush Securities Inc. now owns 3,983 shares of the medical instruments supplier’s stock valued at $351,000 after acquiring an additional 271 shares in the last quarter. 99.66% of the stock is currently owned by hedge funds and other institutional investors.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.